ROPEGINTERFERON ALFA-2B
ROPEGINTERFERON ALFA-2B is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including BESREMi. Available dosage form: injection.
Drug Details
- Generic Name
- ROPEGINTERFERON ALFA-2B
- Brand Names
- BESREMi
- Application Number
- BLA761166
- Sponsor
- PharmaEssentia USA
- NDC Codes
- 1
- Dosage Forms
- INJECTION
- Routes
- SUBCUTANEOUS
- Active Ingredients
- ROPEGINTERFERON ALFA-2B
Indications and Usage
1 INDICATIONS AND USAGE BESREMi is indicated for the treatment of adults with polycythemia vera. BESREMi is an interferon alfa-2b indicated for the treatment of adults with polycythemia vera ( 1 )